Artificial sweeteners are used as calorie-free sugar substitutes in many food products and their consumption has increased substantially over the past years1. Although generally regarded as safe, some concerns have been raised about the long-term safety of the consumption of certain sweeteners2-5. In this study, we show that the intake of high doses of sucralose in mice results in immunomodulatory effects by limiting T cell proliferation and T cell differentiation. Mechanistically, sucralose affects the membrane order of T cells, accompanied by a reduced efficiency of T cell receptor signalling and intracellular calcium mobilization. Mice given sucralose show decreased CD8+ T cell antigen-specific responses in subcutaneous cancer models and bacterial infection models, and reduced T cell function in models of T cell-mediated autoimmunity. Overall, these findings suggest that a high intake of sucralose can dampen T cell-mediated responses, an effect that could be used in therapy to mitigate T cell-dependent autoimmune disorders.
FörderungenFrancis Crick Institute from Cancer Research UK UK Medical Research Council Wellcome Trust Cancer Research UK EMBO Long-Term Fellowship Marie Sklodowska-Curie Individual Fellowship Kuok Family Fellowship MRC New Investigator Research Grant European Research Council ERC (STG grant AstroNeuroCrosstalk) German Research Foundation DFG under Germany's Excellence Strategy DFG under Helmholtz Excellence Network Deutsche Forschungsgemeinschaft Helmholtz Association-Initiative and Networking Fund European Research Council (ERC) Marie Curie Actions (MSCA)